Pharmacotherapy of otitis media

Area of Science:

• Otolaryngology
• Pediatrics
• Infectious Diseases

Background:

• Acute otitis media (AOM) and otitis media with effusion (OME) are frequently caused by abnormal eustachian tube function, typically due to inflammation from infection or allergies.
• Bacterial infections, primarily from Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis, are the main culprits in middle ear infections.
• AOM is highly prevalent in young children, with nearly half experiencing an episode by age 1 and over 70% by age 3.

Purpose of the Study:

• To outline the clinical manifestations, common causes, and typical treatment strategies for acute otitis media and otitis media with effusion.
• To provide guidance on antibiotic selection based on local pathogen resistance patterns.
• To discuss potential complications and long-term management for chronic cases.

Main Methods:

• Clinical review of acute otitis media and otitis media with effusion.
• Summary of common bacterial pathogens involved in middle ear infections.
• Analysis of current therapeutic recommendations, including antibiotic choices and adjuvant therapies.

Main Results:

• Clinical signs include ear pain, fever, irritability, lethargy, and hearing loss, all linked to eustachian tube dysfunction.
• Amoxicillin is the first-line antibiotic choice unless beta-lactamase-producing strains are common.
• Alternative antibiotics like cefaclor, amoxicillin-clavulanate, or cotrimoxazole are recommended for resistant infections. Decongestants offer no proven benefit.

Conclusions:

• Antibiotic therapy is the cornerstone for treating AOM and OME, aiming to prevent complications and alleviate symptoms.
• Antibiotic selection should be guided by local antimicrobial resistance data for common middle ear pathogens.
• Chronic otitis media may necessitate long-term antibiotic prophylaxis or surgical intervention, such as tympanostomy tube insertion.